| Director Dealings Summary - Week Ended June 12 | ||||||||||||
| Company | Name | Position | Number of Shares | Resulting Holding | *Note | GBP Value | ||||||
| BUYS | ||||||||||||
| Utilitywise | Jeremy Middleton | Non-Executive Director | 300,000 | 2,600,000 | Middleton is also co-founder of Homeserve and formerly the Conservative Party’s deputy chairman. | 786,000 | ||||||
| Avesco | Graham Andrews | Director | 270,000 | 562,183 | Same day as Avesco said it swung to profit in H1 and said outlook for H2 is just as encouraging, meaning its full year results are again likely to exceed previous expectations. | 472,500 | ||||||
| Porta Communications | Bob Morton | Chairman | 6,300,000 | 42,600,000 | Bought via Hawk Investments Holdings, a company beneficially owned by Morton and his wife. | 441,000 | ||||||
| Avesco | David Crump | Director | 200,000 | 416,384 | Same day as Avesco said it swung to profit in H1 and said outlook for H2 is just as encouraging, meaning its full year results are again likely to exceed previous expectations. | 350,000 | ||||||
| Stilo International | David Ashman | Chairman | 5,000,000 | 20,200,000 | 150,000 | |||||||
| Advanced Oncotherapy | Michael Bradfield | Non-Executive Director | 1,500,000 | 122,000,000 | 2 days after posting widened pretax loss for 2014 as a result reorganisation of its business and development of LIGHT proton therapy system. | 135,000 | ||||||
| Avesco | John Christmas | CFO | 50,000 | 200,371 | Same day as Avesco said it swung to profit in H1 and said outlook for H2 is just as encouraging, meaning its full year results are again likely to exceed previous expectations. | 87,500 | ||||||
| National Grid | Jonathan Dawson | Non-Executive Director | 10,000 | 35,179 | Bought shares for wife. | 85,200 | ||||||
| Oxford BioMedica | Daniel Soland | Non-Executive Director | 500,000 | 14,000,000 | 47,250 | |||||||
| Carclo | Christopher Malley | CEO | 30,000 | 73,385 | 43,800 | |||||||
| Goldbridges | Ken Crichton | CTO | 1,400,000 | 1,400,000 | 2 days before chairman told shareholders that company's current share price doesn't reflect the true value of the company and is in a position to generate profit from producing gold. | 32,200 | ||||||
| Thalassa Holdings | Duncan Soukup | Chairman | 50,000 | 3,162,571 | Same day as Thalassa said 2014 was an "annus horribilis" in financial terms as it swung to pretax loss after revenue halved and booked substantial amount of impairments and provisions. | 29,000 | ||||||
| Marks & Spencer | Richard Solomons | Non-Executive Director | 5,000 | 5,000 | Appointed in April. | 27,850 | ||||||
| Pittards | Stephen Yapp | Non-Executive Director | 20,000 | 20,000 | Yapp was appointed on June 4 and is also chairman of Journey Group. | 24,800 | ||||||
| Amara Mining | Pete Gardner | CFO | 136,356 | 1,100,000 | 19,949 | |||||||
| Advanced Oncotherapy | Sanjee Pandya | CEO | 220,000 | 590,400 | 2 days after posting widened pretax loss for 2014 as a result reorganisation of its business and development of LIGHT proton therapy system. | 19,800 | ||||||
| Advanced Oncotherapy | Nicolas Serandour | CFO | 220,000 | 220,000 | Appointed in September 2014. | 19,800 | ||||||
| British American Tobacco | Ben Stevens | CFO | 536 | 120,807 | Week after BAT said its Imperial Tobacco Canada subsidiary was ordered to pay CAD15.6 billion in a case that has been running for 10 years after smokers claimed that companies failed to warn them of the risks associated with smoking. | 18,278 | ||||||
| Carclo | Michael Derbyshire | Chairman | 10,000 | 60,000 | Day after swinging to loss. | 14,600 | ||||||
| Picton Property | Nick Thompson | Chairman | 15,164 | 118,366 | Same day Picton reported higher returns, earnings and asset values during last financial year and bought two office buildings in Chatham, Kent for GBP19.05 million, reflecting net initial yield of 8.62%. | 10,827 | ||||||
| Paternoster Resources | Nicholas Lee | Chairman | 3,000,000 | 4,600,000 | 2 days after it said pretax loss widened in 2014 as net asset value rose but the net gain made on investments fell. | 6,000 | ||||||
| Paternoster Resources | Matt Lofgran | Director | 3,000,000 | 4,600,000 | 2 days after it said pretax loss widened in 2014 as net asset value rose but the net gain made on investments fell. | 6,000 | ||||||
| Aureus Mining | Karin Ireton | Non-Executive Director | 17,000 | 52,000 | 4,760 | |||||||
| Tricorn | Andrew Moss | Chairman | 20,000 | 20,000 | Same day as Tricorn posted narrowed pretax loss. | 4,000 | ||||||
| SELLS | ||||||||||||
| Howden Joinery | Robert Fenwick | COO | 869,383 | 533,147 | Sold by wife. | 4,433,853 | ||||||
| Howden Joinery | David Hallett | CIO | 250,000 | 733,337 | Sold by wife. | 1,262,500 | ||||||
| Avesco | Richard Murray | Chairman | 540,000 | 5,181,211 | Sold shares to colleagues, retaining 27% stake in the firm. | 945,000 | ||||||
| Hiscox | Steve Langan | CMO | 98,000 | 120,268 | 835,940 | |||||||
| NAHL | Steve Dolton | CFO | 200,000 | 651,498 | 620,000 | |||||||
| Powerflute | Dermot Smurfitt | Non-Executive Director | 496,944 | 1,500,000 | Former Deputy Chairman of Jefferson Smurfit, now Smurfit Kappa. | 323,014 | ||||||
| Evraz | Marat Atnashev | Divisional VP | 194,855 | Undisclosed | 302,025 | |||||||
| Barclays | Amer Sajed | Interim CEO, Barclaycard division | 72,895 | Undisclosed | 197,545 | |||||||
| Renew Holdings | John Samuel | CFO | 60,000 | 240,548 | 6 days after ex-dividend date. | 186,600 | ||||||
| OMG | Nick Bolton | CEO | 401,916 | 1,200,000 | Same day as OMG announced a further special dividend following the sale of its 2d3 defence software division to Insitu Inc. | 178,853 | ||||||
| HSBC | Alan Keir | CEO of HSBC Bank | 25,253 | Undisclosed | 153,791 | |||||||
| Howden Joinery | Julie French | HR Director | 30,000 | 259,244 | 152,700 | |||||||
| Exova | Hicham Abdallah | Regional manager | 80,000 | 241,036 | 5 days before Exova won GBP2.5 million deal for Angolan Deepwater project. | 152,000 | ||||||
| Cambridge Cognition | Andy Blackwell | CSO | 150,000 | 131,095 | 120,000 | |||||||
| OMG | Cathy Robertson | Company Secretary | 176,000 | 1,300,000 | Same day as OMG announced a further special dividend following the sale of its 2d3 defence software division to Insitu Inc. | 78,320 | ||||||
| Savills | Chris Lee | Legal Director | 5,000 | 77,688 | 46,650 | |||||||
| *Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event. When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director. | ||||||||||||
| Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam | ||||||||||||
| Copyright 2015 Alliance News Limited. All Rights Reserved. | ||||||||||||
3 May 2024 21:30
IN BRIEF: Advanced Oncotherapy financing talks continue, funds delayed
Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Provides update in relation to financing discussions and financial position. Says talks on the proposed financing have continued to make good progress. However, notes there have been further delays and the initial tranche of funding, which is still expected to be around USD15 million, has not yet been received. Hopes this will be received by the end of May but stresses there is no guarantee. Continues to expect the financing to require a restructuring of financial liabilities with a view to providing a long-term financing solution for the company to continue as a going concern. Warns that without additional funding the company is unlikely to be able to continue to trade and would very likely become insolvent and be placed into administration.
Read more